1. Home
  2. EB vs TRDA Comparison

EB vs TRDA Comparison

Compare EB & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eventbrite Inc.

EB

Eventbrite Inc.

N/A

Current Price

$4.43

Market Cap

432.7M

Sector

Technology

ML Signal

N/A

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$11.23

Market Cap

386.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EB
TRDA
Founded
2003
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
432.7M
386.8M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
EB
TRDA
Price
$4.43
$11.23
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.00
$20.00
AVG Volume (30 Days)
2.7M
216.3K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$294,798,000.00
$61,520,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.74
$3.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.81
$4.93
52 Week High
$4.46
$18.96

Technical Indicators

Market Signals
Indicator
EB
TRDA
Relative Strength Index (RSI) 84.03 70.29
Support Level $2.44 $10.82
Resistance Level $4.46 $11.24
Average True Range (ATR) 0.02 0.54
MACD 0.04 -0.02
Stochastic Oscillator 98.77 82.70

Price Performance

Historical Comparison
EB
TRDA

About EB Eventbrite Inc.

Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: